New drug duo targets tough cancers with KRAS mutation
NCT ID NCT06166836
First seen Jan 17, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This study tests two experimental drugs, D-1553 and IN10018, together in people with advanced solid tumors that have a specific change in the KRAS gene (G12C). The goal is to find the safest and most effective dose and see if the combination can shrink tumors. About 140 adults whose cancer has worsened after standard treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
First Affiliated Hospital of Bengbu Medical College
Bengbu, China
-
First Affiliated Hospital of Gannan Medical University
Ganzhou, China
-
Fujian Cancer Hospital
Fuzhou, China
-
General Hospital Of Eastern Theater Command
Nanjing, China
-
Henan Cancer Hospital
Zhengzhou, China
-
Hunan Cancer Hospital
Changsha, China
-
Renmin Hospital of Wuhan University
Wuhan, China
-
The first Affiliated Hospital of Zhengzhou University
Zhengzhou, China
-
Xuzhou Central Hospital
Xuzhou, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310005, China
Conditions
Explore the condition pages connected to this study.